Aktie A14NHS PEAK PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Peak Pharmaceuticals, Inc. Other OTC

Aktien

A14NHS

US70469W1062

CTCO

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
Retrieve Medical Holdings, Inc. Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange
Retrieve Medical Announces Significant Results from Physician Burnout Study
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
Retrieve Medical Advances Healthcare Documentation in Louisiana with New Software Implementation
Retrieve Medical Holdings, Inc. (RMHI) Announces Study Update Results Utilizing Retrieve Dx ™ Software
Retrieve Medical Holdings, Inc. Announces Study Update Results Utilizing Retrieve Dx ? Software
Retrieve Medical Holdings Inc announced that it expects to receive $3 million in funding
Retrieve Medical Holdings, Inc. Forges Partnership with Louisiana Health System Hospitals
Retrieve Medical, Inc. Forges Partnership with Louisiana Health System Hospitals
Retrieve Medical Holdings, Inc. Announces Patent for Enhancing Electronic Health Records
Retrieve Medical. Inc. Announces Signed Letter of Intent with Louisiana Health System Hospitals, to Immediately Begin the Implementation Phase of Their Patented Software Solution, Retrieve DX
Retrieve Medical Holdings, Inc. Announces Study Results Utilizing Retrieve Dx Software
Peak Pharmaceuticals, Inc. announced that it has received $0.3185 million in funding
Retrieve Medical. Inc. Announces New Contract with Healthcare Enterprise Technology Company
Retrieve Medical, Inc. Announce Signed Contract with Regional Medical Center
Peak Pharmaceuticals, Inc. announced that it expects to receive $0.3185 million in funding
Neil Reithinger Resigns as Sole Director of Peak Pharmaceuticals, Inc
Neil Reithinger Resigns as Chief Financial Officer of Peak Pharmaceuticals, Inc
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3D7B6 Aktie
  4. A14NHS Aktie
  5. Nachrichten Peak Pharmaceuticals, Inc.
  6. Andere Sprachen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT